Literature DB >> 11075909

Vector-host interactions in disease transmission.

P A Nuttall1, G C Paesen, C H Lawrie, H Wang.   

Abstract

Tick-borne spirochetes include borreliae that cause Lyme disease and relapsing fever in humans. They survive in a triangle of parasitic interactions between the spirochete and its vertebrate host, the spirochete and its tick vector, and the host and the tick. Until recently, the significance of vector-host interactions in the transmission of arthropod-borne disease agents has been overlooked. However, there is now compelling evidence that the pharmacological activity of tick saliva can have a profound effect on pathogen transmission both from infected tick to uninfected host, and from infected host to uninfected tick. The salivary glands of ticks provide a pharmacopoeia of anti-inflammatory, anti-haemostatic and anti-immune molecules. These include bioactive proteins that control histamine, bind immunoglobulins, and inhibit the alternative complement cascade. The effect of these molecules is to provide a privileged site at the tick-host interface in which borreliae and other tick-borne pathogens are sheltered from the normal innate and acquired host immune mechanisms that combat infections. Understanding the key events at the tick vector-host interface, that promote spirochete infection and transmission, will provide a better understanding of the epidemiology and ecology of these important human pathogens.

Entities:  

Mesh:

Year:  2000        PMID: 11075909

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  21 in total

1.  Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.

Authors:  J Piesman; B S Schneider; N S Zeidner
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Saliva, salivary gland, and hemolymph collection from Ixodes scapularis ticks.

Authors:  Toni G Patton; Gabrielle Dietrich; Kevin Brandt; Marc C Dolan; Joseph Piesman; Robert D Gilmore
Journal:  J Vis Exp       Date:  2012-02-21       Impact factor: 1.355

3.  Inhibition of neutrophil function by two tick salivary proteins.

Authors:  Xiuyang Guo; Carmen J Booth; Michael A Paley; Xiaomei Wang; Kathleen DePonte; Erol Fikrig; Sukanya Narasimhan; Ruth R Montgomery
Journal:  Infect Immun       Date:  2009-03-30       Impact factor: 3.441

4.  Two immunoregulatory peptides with antioxidant activity from tick salivary glands.

Authors:  Jing Wu; Yipeng Wang; Han Liu; Hailong Yang; Dongying Ma; Jianxu Li; Dongsheng Li; Ren Lai; Haining Yu
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

5.  How ticks keep ticking in the adversity of host immune reactions.

Authors:  Rachel Jennings; Yang Kuang; Horst R Thieme; Jianhong Wu; Xiaotian Wu
Journal:  J Math Biol       Date:  2018-11-26       Impact factor: 2.259

6.  Humoral immunity reflects altered T helper cell bias in Borrelia burgdorferi-infected gamma delta T-cell-deficient mice.

Authors:  Linda K Bockenstedt; Marie-Claude Shanafelt; Alexia Belperron; Jialing Mao; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 7.  Thrombin inhibitors from different animals.

Authors:  A M Tanaka-Azevedo; K Morais-Zani; R J S Torquato; A S Tanaka
Journal:  J Biomed Biotechnol       Date:  2010-10-04

8.  Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent.

Authors:  Jianfeng Dai; Sukanya Narasimhan; Lili Zhang; Lei Liu; Penghua Wang; Erol Fikrig
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

9.  The decrease in FlaA observed in a flaB mutant of Borrelia burgdorferi occurs posttranscriptionally.

Authors:  M A Motaleb; Melanie S Sal; Nyles W Charon
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

10.  Anti-complement activity of the Ixodes scapularis salivary protein Salp20.

Authors:  Dennis E Hourcade; Antonina M Akk; Lynne M Mitchell; Hui-fang Zhou; Richard Hauhart; Christine T N Pham
Journal:  Mol Immunol       Date:  2015-12-08       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.